Company & Sponsor Intelligence

Cedars-Sinai Medical Center

Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.

Request enterprise analysis →

Indexed trials7

Recruiting3

Completed3

Countries1

Therapeutic footprint

alzheimersanxietydepressionpain_neuropathyparkinsons

Indexed studies

NCT07299474Efficacy of Lavender Aromatherapy on Anxiety and Pain Reduction During Awake Otolaryngologic Procedures
anxiety · United StatesNA

NCT02953665Safety and Efficacy of Liraglutide in Parkinson's Disease
parkinsons · United StatesPHASE2

NCT02442739Ketamine for Preventing Depression in Patients Undergoing Treatment for Pancreatic or Head and Neck Cancers
depression · United StatesEARLY_PHASE1

NCT02667847Preoperative Anxiety Evaluation: a New Visual Smileys Scale
anxiety · United StatesCOMPLETED

NCT07671313Online Pain Education for Crohn's Disease and Ulcerative Colitis
pain_neuropathy · United StatesNA

NCT05109364Terazosin and Parkinson's Disease Extension Study
parkinsons · United StatesPHASE2

NCT00654563Memory Disorders Registry
alzheimers · United StatesCOMPLETED

Intelligence layer updated: 2026-10-29 06:17:44.639239+00:00

Enterprise intelligence

Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.

Request comparative intelligence →